
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.5B | $1.4B | $1.3B | $977.1M | |
Revenue Growth (YoY) | -8.66% | 21.67% | -2.14% | -9.94% | -24.1% | |
Cost of Revenues | $661.7M | $764.5M | $874.1M | $745.7M | $639M | |
Gross Profit | $539M | $696.4M | $555.4M | $541.7M | $338.2M | |
Gross Profit Margin | 44.89% | 47.67% | 38.85% | 42.08% | 34.61% | |
R&D Expenses | $126.9M | $139.6M | $116.1M | $98.7M | $109.8M | |
Selling, General & Admin | $180.6M | $204.1M | $207.9M | $211.4M | $213.9M | |
Other Inc / (Exp) | -$32.1M | $15.6M | -$60.7M | $1.6M | -$221.8M | |
Operating Expenses | $307.5M | $343.6M | $324M | $310.1M | $323.7M | |
Operating Income | $231.5M | $352.8M | $231.4M | $231.6M | $14.5M | |
Net Interest Expenses | -- | $1.8M | -- | -- | -- | |
EBT. Incl. Unusual Items | $205.7M | $366.5M | $183.4M | $274.9M | -$161.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $45.4M | $88.6M | $72.6M | $56M | $19.6M | |
Net Income to Company | $160.3M | $277.9M | $110.8M | $218.9M | -$181.5M | |
Minority Interest in Earnings | -$766K | $550K | -$853K | -- | -- | |
Net Income to Common Excl Extra Items | $159.6M | $278.4M | $109.9M | $218.9M | -$181.5M | |
Basic EPS (Cont. Ops) | $3.00 | $5.21 | $2.17 | $4.64 | -$4.09 | |
Diluted EPS (Cont. Ops) | $2.97 | $5.16 | $2.16 | $4.63 | -$4.09 | |
Weighted Average Basic Share | $53.2M | $53.4M | $50.8M | $47.2M | $44.3M | |
Weighted Average Diluted Share | $53.8M | $53.9M | $50.9M | $47.3M | $44.3M | |
EBITDA | $326.1M | $449.1M | $322M | $301.2M | $75.9M | |
EBIT | $231.5M | $352.8M | $231.4M | $231.6M | $14.5M | |
Revenue (Reported) | $1.2B | $1.5B | $1.4B | $1.3B | $977.1M | |
Operating Income (Reported) | $231.5M | $352.8M | $231.4M | $231.6M | $14.5M | |
Operating Income (Adjusted) | $231.5M | $352.8M | $231.4M | $231.6M | $14.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $345.6M | $370M | $347.2M | $252M | $227.8M | |
Revenue Growth (YoY) | 38.65% | 7.06% | -6.16% | -27.41% | -9.61% | |
Cost of Revenues | $181.6M | $198.2M | $200.2M | $154.5M | $138M | |
Gross Profit | $164M | $171.8M | $146.9M | $97.5M | $89.8M | |
Gross Profit Margin | 47.45% | 46.44% | 42.32% | 38.7% | 39.43% | |
R&D Expenses | $33.3M | $33.5M | $22.8M | $29.4M | $28.3M | |
Selling, General & Admin | $49M | $51M | $51.2M | $54.2M | $57.2M | |
Other Inc / (Exp) | $7.4M | $5.6M | $2.8M | $5.4M | -$1.1M | |
Operating Expenses | $82.3M | $84.5M | $74M | $83.5M | $85.6M | |
Operating Income | $81.7M | $87.3M | $73M | $14M | $4.2M | |
Net Interest Expenses | $495K | $70K | -- | -- | -- | |
EBT. Incl. Unusual Items | $88.6M | $92.8M | $83.3M | $33.6M | $10.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.4M | $23.2M | $23.2M | $9.5M | $6.9M | |
Net Income to Company | $68.2M | $69.6M | $60.1M | $24.1M | $3.8M | |
Minority Interest in Earnings | -$95K | -$56K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $68.1M | $69.6M | $60.1M | $24.1M | $3.8M | |
Basic EPS (Cont. Ops) | $1.27 | $1.32 | $1.26 | $0.52 | $0.09 | |
Diluted EPS (Cont. Ops) | $1.26 | $1.31 | $1.26 | $0.52 | $0.09 | |
Weighted Average Basic Share | $53.5M | $52.8M | $47.5M | $46M | $42.6M | |
Weighted Average Diluted Share | $54.2M | $53.1M | $47.8M | $46.2M | $42.8M | |
EBITDA | $112.9M | $110.8M | $90.8M | $30.2M | $19.6M | |
EBIT | $89.1M | $87.3M | $73M | $14M | $4.2M | |
Revenue (Reported) | $345.6M | $370M | $347.2M | $252M | $227.8M | |
Operating Income (Reported) | $81.7M | $87.3M | $73M | $14M | $4.2M | |
Operating Income (Adjusted) | $89.1M | $87.3M | $73M | $14M | $4.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.3B | $1.5B | $1.4B | $1.2B | $952.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $697M | $781M | $876.2M | $700M | $622.5M | |
Gross Profit | $600.1M | $704.2M | $530.5M | $492.3M | $330.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $128.4M | $139.7M | $105.4M | $105.3M | $108.7M | |
Selling, General & Admin | $183.8M | $206.1M | $208.1M | $214.4M | $217M | |
Other Inc / (Exp) | -$44.4M | $13.7M | -$63.4M | $4.2M | -$228.3M | |
Operating Expenses | $312.2M | $345.8M | $313.5M | $319.7M | $325.7M | |
Operating Income | $288M | $358.4M | $217M | $172.6M | $4.7M | |
Net Interest Expenses | -- | $1.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | $246.2M | $370.7M | $173.8M | $225.2M | -$184.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $54.4M | $91.4M | $72.5M | $42.3M | $17M | |
Net Income to Company | $191.8M | $279.3M | $101.3M | $182.8M | -$201.9M | |
Minority Interest in Earnings | -$498K | $589K | -$797K | -- | -- | |
Net Income to Common Excl Extra Items | $191.3M | $279.9M | $100.5M | $182.8M | -$201.9M | |
Basic EPS (Cont. Ops) | $3.58 | $5.26 | $1.93 | $3.89 | -$4.61 | |
Diluted EPS (Cont. Ops) | $3.55 | $5.21 | $1.92 | $3.88 | -$4.61 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $389.6M | $454.4M | $302M | $240.6M | $65.3M | |
EBIT | $295.4M | $358.4M | $217M | $172.6M | $4.7M | |
Revenue (Reported) | $1.3B | $1.5B | $1.4B | $1.2B | $952.9M | |
Operating Income (Reported) | $288M | $358.4M | $217M | $172.6M | $4.7M | |
Operating Income (Adjusted) | $295.4M | $358.4M | $217M | $172.6M | $4.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $345.6M | $370M | $347.2M | $252M | $227.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $181.6M | $198.2M | $200.2M | $154.5M | $138M | |
Gross Profit | $164M | $171.8M | $146.9M | $97.5M | $89.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $33.3M | $33.5M | $22.8M | $29.4M | $28.3M | |
Selling, General & Admin | $49M | $51M | $51.2M | $54.2M | $57.2M | |
Other Inc / (Exp) | $7.4M | $5.6M | $2.8M | $5.4M | -$1.1M | |
Operating Expenses | $82.3M | $84.5M | $74M | $83.5M | $85.6M | |
Operating Income | $81.7M | $87.3M | $73M | $14M | $4.2M | |
Net Interest Expenses | $495K | $70K | -- | -- | -- | |
EBT. Incl. Unusual Items | $88.6M | $92.8M | $83.3M | $33.6M | $10.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.4M | $23.2M | $23.2M | $9.5M | $6.9M | |
Net Income to Company | $68.2M | $69.6M | $60.1M | $24.1M | $3.8M | |
Minority Interest in Earnings | -$95K | -$56K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $68.1M | $69.6M | $60.1M | $24.1M | $3.8M | |
Basic EPS (Cont. Ops) | $1.27 | $1.32 | $1.26 | $0.52 | $0.09 | |
Diluted EPS (Cont. Ops) | $1.26 | $1.31 | $1.26 | $0.52 | $0.09 | |
Weighted Average Basic Share | $53.5M | $52.8M | $47.5M | $46M | $42.6M | |
Weighted Average Diluted Share | $54.2M | $53.1M | $47.8M | $46.2M | $42.8M | |
EBITDA | $112.9M | $110.8M | $90.8M | $30.2M | $19.6M | |
EBIT | $89.1M | $87.3M | $73M | $14M | $4.2M | |
Revenue (Reported) | $345.6M | $370M | $347.2M | $252M | $227.8M | |
Operating Income (Reported) | $81.7M | $87.3M | $73M | $14M | $4.2M | |
Operating Income (Adjusted) | $89.1M | $87.3M | $73M | $14M | $4.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $876.2M | $709.1M | $698.2M | $514.7M | $620M | |
Short Term Investments | $514.8M | $805.4M | $479.4M | $662.8M | $310.2M | |
Accounts Receivable, Net | $264.3M | $262.1M | $211.3M | $219.1M | $171.1M | |
Inventory | $365M | $460.7M | $509.4M | $453.9M | $284.8M | |
Prepaid Expenses | $69.9M | $37M | $40.9M | $26M | $17.6M | |
Other Current Assets | $57.8M | $73.3M | $47M | $38.2M | $27.3M | |
Total Current Assets | $2.1B | $2.3B | $2B | $1.9B | $1.4B | |
Property Plant And Equipment | $597.5M | $635.3M | $580.6M | $602.3M | $588.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $41.4M | $38.6M | $38.3M | $38.5M | $67.2M | |
Other Intangibles | $62.1M | $52.7M | $34.1M | $26.2M | $55.4M | |
Other Long-Term Assets | $43.4M | $48.5M | $28.8M | $28.4M | $32.2M | |
Total Assets | $2.9B | $3.2B | $2.7B | $2.7B | $2.3B | |
Accounts Payable | $25.7M | $55.8M | $46.2M | $28.6M | $35.4M | |
Accrued Expenses | $36.9M | $26.2M | $28.5M | $27.3M | $21.4M | |
Current Portion Of Long-Term Debt | $3.8M | $18.1M | $16M | -- | -- | |
Current Portion Of Capital Lease Obligations | $5.8M | $5.5M | $5.2M | $4.6M | $4.8M | |
Other Current Liabilities | -- | $14.7M | $10.7M | $13.2M | $12.8M | |
Total Current Liabilities | $214.6M | $313.4M | $274.6M | $214.9M | $205M | |
Long-Term Debt | $34.2M | $16M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $341.6M | $423.3M | $357.9M | $283.5M | $264.8M | |
Common Stock | $6K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | -$146.1M | -$184K | $152K | -- | -$119.4M | |
Common Equity | $2.6B | $2.7B | $2.4B | $2.4B | $2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.3M | $639K | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $2.4B | $2.4B | $2B | |
Total Liabilities and Equity | $2.9B | $3.2B | $2.7B | $2.7B | $2.3B | |
Cash and Short Terms | $1.4B | $1.5B | $1.2B | $1.2B | $930.2M | |
Total Debt | $38M | $34.2M | $16M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $896.7M | $642.5M | $521.1M | $496.5M | $363M | |
Short Term Investments | $548.2M | $774.2M | $548.5M | $643.7M | $563.8M | |
Accounts Receivable, Net | $252.9M | $257.5M | $236.6M | $184M | $176.9M | |
Inventory | $368.1M | $485M | $506.1M | $431.9M | $287.6M | |
Prepaid Expenses | $70.4M | $40.9M | $47.1M | $24.5M | $17M | |
Other Current Assets | $65.9M | $82.8M | $56.2M | $49.1M | $35M | |
Total Current Assets | $2.2B | $2.3B | $1.9B | $1.8B | $1.4B | |
Property Plant And Equipment | $600.9M | $625.4M | $594.3M | $585.8M | $603.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $38.8M | $39.7M | $38.4M | $38.4M | $68.6M | |
Other Intangibles | $61.8M | $50M | $32.1M | $24.8M | $54.3M | |
Other Long-Term Assets | $38M | $50.6M | $31.7M | $35.5M | $38.5M | |
Total Assets | $3B | $3.1B | $2.7B | $2.6B | $2.3B | |
Accounts Payable | $44.7M | $46.5M | $40.9M | $26.7M | $37.9M | |
Accrued Expenses | $34M | $41.1M | $28.8M | $25.9M | $20.5M | |
Current Portion Of Long-Term Debt | $3.8M | $17.5M | $15.7M | -- | -- | |
Current Portion Of Capital Lease Obligations | $5.6M | $5.8M | $5M | $4.6M | $4.3M | |
Other Current Liabilities | -- | -- | $12.7M | $17M | $12.4M | |
Total Current Liabilities | $214.8M | $279.8M | $249.5M | $192.1M | $197M | |
Long-Term Debt | $33.2M | $15.7M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $342.3M | $390.2M | $332.6M | $257.7M | $256.9M | |
Common Stock | $6K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | -$178.3M | -$229.4M | -$204.1M | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.2M | $1M | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $2.3B | $2.3B | $2.1B | |
Total Liabilities and Equity | $3B | $3.1B | $2.7B | $2.6B | $2.3B | |
Cash and Short Terms | $1.4B | $1.4B | $1.1B | $1.1B | $926.9M | |
Total Debt | $37M | $33.2M | $15.7M | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $160.3M | $277.9M | $110.8M | $218.9M | -$181.5M | |
Depreciation & Amoritzation | $94.6M | $96.3M | $90.6M | $69.6M | $61.4M | |
Stock-Based Compensation | $35.5M | $37.9M | $38.3M | $39.5M | $37.1M | |
Change in Accounts Receivable | -$13M | -$2.1M | $34.1M | -$10.4M | $46.8M | |
Change in Inventories | -$39.9M | -$149.8M | -$189M | $1.8M | $47.7M | |
Cash From Operations | $285.3M | $389.7M | $212.6M | $296M | $247.9M | |
Capital Expenditures | $87.7M | $123.1M | $110.1M | $110.5M | $98.5M | |
Cash Acquisitions | -$429K | -- | $50.9M | -- | -$92.1M | |
Cash From Investing | -$99.6M | -$416.3M | $297M | -$237.6M | $208.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$3.7M | -$3.8M | -$18.1M | -$16M | -- | |
Repurchase of Common Stock | -$37.9M | -$134.9M | -$499.5M | -$223.5M | -$343.8M | |
Other Financing Activities | -$1.7M | -$2.6M | -$2.5M | -- | -- | |
Cash From Financing | -$10.1M | -$125.1M | -$514.5M | -$236.4M | -$339.6M | |
Beginning Cash (CF) | $683M | $878.6M | $709.1M | $698.2M | $514.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $175.7M | -$151.6M | -$4.9M | -$177.9M | $117M | |
Ending Cash (CF) | $878.6M | $709.1M | $698.2M | $514.7M | $620M | |
Levered Free Cash Flow | $197.6M | $266.6M | $102.5M | $185.5M | $149.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $69.7M | $57.3M | $62.3M | $20.2M | -- | |
Depreciation & Amoritzation | $24.2M | $23.7M | $17.5M | $15.3M | -- | |
Stock-Based Compensation | $9.9M | $10.4M | $9.7M | $8.5M | -- | |
Change in Accounts Receivable | $5.2M | -$1.1M | $766K | $6.2M | -- | |
Change in Inventories | -$41.1M | -$48.3M | -$3.1M | $15.5M | -- | |
Cash From Operations | $115.6M | $78.7M | $66.7M | $53.5M | -- | |
Capital Expenditures | $26.9M | $34.7M | $25.7M | $24.2M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$222.9M | $277.8M | $5.5M | $284.9M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$950K | -$968K | -$15.7M | -- | -- | |
Repurchase of Common Stock | -$38.7M | -$232.8M | $63K | -$122.4M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$34M | -$231M | -$12.6M | -$119.5M | -- | |
Beginning Cash (CF) | $896.7M | $642.5M | $521.1M | $496.5M | -- | |
Foreign Exchange Rate Adjustment | -$1.2M | $3.8M | -$7.7M | $5.2M | -- | |
Additions / Reductions | -$141.3M | $125.5M | $59.6M | $218.9M | -- | |
Ending Cash (CF) | $754.2M | $771.8M | $573.1M | $720.5M | -- | |
Levered Free Cash Flow | $88.7M | $44M | $40.9M | $29.2M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $191.8M | $279.3M | $101.3M | $182.8M | -$201.9M | |
Depreciation & Amoritzation | $94.3M | $95.9M | $85M | $67.9M | $60.6M | |
Stock-Based Compensation | $35.9M | $39M | $37.9M | $39.7M | $38.1M | |
Change in Accounts Receivable | -$40.2M | -$6.8M | $6.8M | $46.6M | $10.4M | |
Change in Inventories | -$49.6M | -$180.6M | -$147.1M | $12.3M | $37.3M | |
Cash From Operations | $316.1M | $318.6M | $233.5M | $313.3M | $206.7M | |
Capital Expenditures | $97.3M | $120.9M | $118.4M | $105.1M | $95.3M | |
Cash Acquisitions | -- | -$2M | $52.9M | -- | -$92.1M | |
Cash From Investing | -$20.5M | -$353.1M | $198.5M | -$117.8M | -$89.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$3.8M | -$3.8M | -$17.5M | -$15.7M | -- | |
Repurchase of Common Stock | -$28.2M | -$210.6M | -$533.8M | -$200M | -- | |
Other Financing Activities | -$2.6M | -- | -- | -- | -- | |
Cash From Financing | $9.1M | -$203.9M | -$551.3M | -$209.9M | -$254.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $304.7M | -$238.4M | -$119.4M | -$14.4M | -$137.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $218.8M | $197.7M | $115.1M | $208.2M | $111.5M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $137.9M | $127M | $122.5M | $44.3M | $3.8M | |
Depreciation & Amoritzation | $48M | $47.1M | $35.3M | $31.5M | $15.3M | |
Stock-Based Compensation | $18.7M | $20.4M | $19.2M | $18.3M | $10.8M | |
Change in Accounts Receivable | $12.5M | $1.6M | -$23.9M | $38.5M | -$4.1M | |
Change in Inventories | -$61.2M | -$99.2M | -$12.1M | $17M | -$9M | |
Cash From Operations | $203.2M | $95.2M | $103.9M | $108.1M | $13.4M | |
Capital Expenditures | $54.3M | $59.9M | $59.1M | $52.3M | $24.8M | |
Cash Acquisitions | -- | -$2M | -- | -- | -- | |
Cash From Investing | -$283.6M | $280.2M | -$90.5M | $308.6M | -$274.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1.9M | -$1.9M | -$16M | -- | -- | |
Repurchase of Common Stock | -$41.7M | -$311.6M | -$113M | -$212M | -- | |
Other Financing Activities | -$2.6M | -- | -- | -- | -- | |
Cash From Financing | -$35.7M | -$311.5M | -$129.8M | -$210.2M | -$5.7M | |
Beginning Cash (CF) | $1.8B | $1.4B | $1.2B | $1B | $620M | |
Foreign Exchange Rate Adjustment | -$8.2M | -$1.2M | -$8.8M | -$604K | $9.6M | |
Additions / Reductions | -$116.1M | $63.9M | -$116.4M | $206.5M | -$266.6M | |
Ending Cash (CF) | $1.7B | $1.4B | $1.1B | $1.2B | $363M | |
Levered Free Cash Flow | $148.8M | $35.3M | $44.8M | $55.8M | -$11.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.